These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 11981600

  • 21. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Acute administration of buprenorphine in humans: partial agonist and blockade effects.
    Walsh SL, Preston KL, Bigelow GE, Stitzer ML.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):361-72. PubMed ID: 7542336
    [Abstract] [Full Text] [Related]

  • 25. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T, Miller JH, Irvine RJ.
    Life Sci; 2006 Jan 11; 78(7):682-8. PubMed ID: 16102783
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1993 Nov 11; 267(2):624-34. PubMed ID: 7504098
    [Abstract] [Full Text] [Related]

  • 28. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF, Koning JP, Heinen N, Laheij RJ, van Cauter RM, De Jong CA.
    Addict Biol; 2003 Sep 11; 8(3):351-8. PubMed ID: 13129838
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Time series modeling of heroin and morphine drug action.
    Tschacher W, Haemmig R, Jacobshagen N.
    Psychopharmacology (Berl); 2003 Jan 11; 165(2):188-93. PubMed ID: 12404073
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):160-6. PubMed ID: 17977528
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B, Bonnet U, Specka M, Augener S, Bachmann HS, Siffert W, Scherbaum N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun 15; 33(4):663-7. PubMed ID: 19303909
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.